MLchartDataset catalogue

SN-38 liposome

Term · Oncology and biomedicine · MLC-T-ONC-007831

A form of the anticancer drug irinotecan that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than irinotecan alone. SN-38 liposome is being studied in the treatment of advanced colorectal cancer and other types of cancer. SN-38 liposome blocks the ability of cells to divide and grow. It may stop the growth of tumor cells. It is a type of topoisomerase inhibitor and a type of irinotecan (CPT-11) derivative. Also called liposomal SN-38.

Table 1. Record
IdentifierMLC-T-ONC-007831
FieldOncology and biomedicine
Synonymsliposomal SN-38
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-007831",
  "term": "SN-38 liposome",
  "field": "Oncology and biomedicine",
  "definition": "A form of the anticancer drug irinotecan that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than irinotecan alone. SN-38 liposome is being studied in the treatment of advanced colorectal cancer and other types of cancer. SN-38 liposome blocks the ability of cells to divide and grow. It may stop the growth of tumor cells. It is a type of topoisomerase inhibitor and a type of irinotecan (CPT-11) derivative. Also called liposomal SN-38.",
  "synonyms": [
    "liposomal SN-38"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/sn-38-liposome/"
}

Record 15,107 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.